Summary: Karol Sikora Medical Director at CancerPartners UK, joins Helen Winsor from Pharma IQ, to discuss new trial design approaches and biomarker application methods coming on stream to drive oncology clinical development. The main focus of this exclusive interview is on assessing molecular
